{
    "eid": "2-s2.0-84930080810",
    "title": "Effective delivery of apomorphine in the management of parkinson disease: Practical considerations for clinicians and parkinson nurses",
    "cover-date": "2015-05-30",
    "subject-areas": [
        {
            "$": "Neurology (clinical)",
            "@code": "2728"
        },
        {
            "$": "Pharmacology",
            "@code": "3004"
        },
        {
            "$": "Pharmacology (medical)",
            "@code": "2736"
        }
    ],
    "keywords": [
        "apomorphine infusion",
        "apomorphine injection",
        "clinical practice",
        "Parkinson disease",
        "pharmacokinetics",
        "treatment"
    ],
    "authors": [
        "Roongroj Bhidayasiri"
    ],
    "citedby-count": 44,
    "ref-count": 111,
    "ref-list": [
        "Nonmotor fluctuations in Parkinson's disease: Frequent and disabling",
        "International multicenter pilot study of the first comprehensive self-completed nonmotor symptoms questionnaire for Parkinson's disease: The NMSQuest study",
        "The challenge of non-motor symptoms in Parkinson's disease",
        "Parkinson's disease: The non-motor issues",
        "The impact of non-motor symptoms on health-related quality of life of patients with Parkinson's disease",
        "Impact of the motor complications of Parkinson's disease on the quality of life",
        "Apomorphine therapy in parkinson's disease: A review",
        "Pramipexole vs Levodopa as initial treatment for Parkinson disease: A randomized controlled trial",
        "Frequency of levodopa-related dyskinesias and motor fluctuations as estimated from the cumulative literature",
        "Dopaminergic Agonists in Parkinson's Disease",
        "Proc R Soc Lond B Biol SC",
        "Lyon Med",
        "Subcutaneously administered apomorphine: Pharmacokinetics and metabolism",
        "Apomorphine in Parkinson's disease.",
        "Apomorphine and Other Dopaminomimetics",
        "Similarities between Neurologic Effects of L-Dopa and of Apomorphine",
        "Subcutaneous infusions of apomorphine: A reappraisal of its therapeutic efficacy in advanced Parkinson's disease",
        "THERAPEUTIC EFFICACY OF APOMORPHINE COMBINED WITH AN EXTRACEREBRAL INHIBITOR OF DOPAMINE RECEPTORS IN PARKINSON'S DISEASE",
        "SUBCUTANEOUS APOMORPHINE IN PARKINSONIAN ON-OFF OSCILLATIONS",
        "Subcutaneous apomorphine for on-off oscillations in Parkinson's disease",
        "SUBCUTANEOUS INFUSION OF APOMORPHINE AND LISURIDE IN THE TREATMENT OF PARKINSONIAN ON-OFF FLUCTUATIONS",
        "Subcutaneous lisuride infusion in parkinson's disease: Response TO chronic ADMINISTRATION in 34 patients",
        "Iontophoretic delivery of apomorphine II: An in vivo study in patients with Parkinson's disease",
        "Transdermal iontophoretic delivery of apomorphine in patients improved by surfactant formulation pretreatment",
        "The Use of Apomorphine in the Treatment of Parkinson's Disease-clinical Practice Recommendations",
        "Mov Disord",
        "EPNN Journal",
        "Treatment approaches of gastrointestinal dysfunction in Parkinson's disease, therapeutical options and future perspectives",
        "Morning akinesia and the potential role of gastroparesis - Managing delayed onset of first daily dose of oral levodopa in patients with Parkinson's disease",
        "Characterizing motor and non-motor aspects of early-morning off periods in Parkinson's disease: An international multicenter study",
        "Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor. I. A multivariate analysis of the binding profiles of 14 drugs at 21 native and cloned human receptor subtypes",
        "Subcutaneous apomorphine: An evidence-based review of its use in Parkinson's disease",
        "Peripheral and central pharmacokinetics of apomorphine and its effect on dopamine metabolism in humans",
        "Pharmacokinetics of apomorphine in Parkinson's disease: Plasma and cerebrospinal fluid levels in relation to motor responses",
        "The short\u2010duration response to apomorphine: Implications for the mechanism of dopaminergic effects in parkinsonism",
        "Peripheral pharmacokinetics of apomorphine in humans",
        "Pharmacokinetics of apomorphine in Parkinson's disease",
        "Pharmacokinetics, enantiomer interconversion, and metabolism of R- apomorphine in patients with idiopathic Parkinson's disease",
        "Pharmacokinetics of apomorphine in parkinsonian patients",
        "Dose response and concentration response relationship of apomorphine in patients with Parkinson's disease and end-of-dose akinesia",
        "Pharmacokinetic optimisation in the treatment of Parkinson's disease: An update",
        "Time course of tolerance to apomorphine in parkinsonism",
        "Apomorphine infusional therapy in parkinson's disease: Clinical utility and lack of tolerance",
        "Tolerance to apomorphine develops and reverses rapidly",
        "The influence of a standard meal on Sinemet CR absorption in patients with Parkinson's disease",
        "Plasma levodopa peak delay and impaired gastric emptying in Parkinson's disease",
        "EMJ Neurol",
        "Twenty years of apomorphine therapy \u2013 how does it compare with Levodopa?: Highlights of a satellite symposium held at the 18th international congress of parkinson\u2019s disease and movement disorders, Stockholm, 8\u201312 june 2014",
        "The apomorphine test in Parkinsonian syndromes",
        "Movement disorder society-sponsored revision of the unified Parkinson's disease rating scale (MDS-UPDRS): Process, format, and clinimetric testing plan",
        "The Unified Parkinson's Disease Rating Scale (UPDRS): Status and recommendations",
        "Short-distance walking speed tests in people with Parkinson disease: Reliability, responsiveness, and validity",
        "Bradykinesia akinesia inco-ordination test (BRAIN TEST): An objective computerised assessment of upper limb motor function",
        "SPC APO-go Pen 10 Mg/mL Solution for Injection, Britannia Pharmacueticals: EMC",
        "APOMORPHINE INFUSION FOR MOTOR FLUCTUATIONS IN PARKINSON'S DISEASE",
        "Subcutaneous continuous apomorphine infusion in fluctuating patients with Parkinson's disease: Long-term results",
        "Continuous subcutaneous apomorphine therapy improves dyskinesias in Parkinson's disease: A prospective study using single-dose challenges",
        "Efficacy of long-term continuous subcutaneous apomorphine infusion in advanced Parkinson's disease with motor fluctuations: A multicenter study",
        "Chronic subcutaneous infusion therapy with apomorphine in advanced Parkinson's disease compared to conventional therapy: A real life study of non motor effect",
        "Comparative cognitive effects of bilateral subthalamic stimulation and subcutaneous continuous infusion of apomorphine in Parkinson's disease",
        "Clinical and neuropsychological follow up at 12 months in patients with complicated Parkinson's disease treated with subcutaneous apomorphine infusion or deep brain stimulation of the subthalamic nucleus",
        "A 5-year prospective assessment of advanced Parkinson disease patients treated with subcutaneous apomorphine infusion or deep brain stimulation",
        "Continuous subcutaneous waking day apomorphine in the long term treatment of levodopa induced interdose dyskinesias in Parkinson's disease",
        "Apomorphine: An underutilized therapy for Parkinson's disease",
        "Identification of motor and nonmotor wearing-off in Parkinson's disease: Comparison of a patient questionnaire versus a clinician assessment",
        "Subcutaneous apomorphine and non-motor symptoms in Parkinson's disease",
        "Continuous apomorphine infusion (CAI) and neuropsychiatric disorders in patients with advanced Parkinson's disease: A follow-up of two years",
        "Continuous subcutaneous infusion of apomorphine can be used safely in patients with Parkinson's disease and pre-existing visual hallucinations",
        "Nocturnal subcutaneous apomorphine infusion in Parkinson's disease and restless legs syndrome",
        "Impulse control disorders in Parkinson's disease: Recent advances",
        "Dopamine and impulse control disorders in Parkinson's disease",
        "Mov Disord",
        "Mov Disord",
        "Mov Disord",
        "Comparison of motor response to apomorphine and levodopa in Parkinson's disease",
        "EuroInf: A multicenter comparative observational study of apomorphine and levodopa infusion in Parkinson's disease",
        "Continuous perioperative apomorphine in deep brain stimulation surgery for Parkinson's disease",
        "Prevalence of nonmotor symptoms in Parkinson's disease in an international setting; study using nonmotor symptoms questionnaire in 545 patients",
        "The Harris Poll",
        "Domperidone: Small Risk of Heart Problems"
    ],
    "affiliation": [
        {
            "affiliation-city": "London",
            "affilname": "King's College Hospital",
            "affiliation-country": "United Kingdom"
        },
        {
            "affiliation-city": "Bangkok",
            "affilname": "King Chulalongkorn Memorial Hospital",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Detroit",
            "affilname": "Wayne State University",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Groningen",
            "affilname": "Universitair Medisch Centrum Groningen",
            "affiliation-country": "Netherlands"
        },
        {
            "affiliation-city": "Los Angeles",
            "affilname": "David Geffen School of Medicine at UCLA",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Bangkok",
            "affilname": "Faculty of Medicine, Chulalongkorn University",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": []
}